JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M201550200 on July 1, 2002

J. Biol. Chem., Vol. 277, Issue 36, 32546-32551, September 6, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/36/32546    most recent
M201550200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, Q.
Right arrow Articles by Ziegelstein, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, Q.
Right arrow Articles by Ziegelstein, R. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Critical Role of NADPH Oxidase-derived Reactive Oxygen Species in Generating Ca2+ Oscillations in Human Aortic Endothelial Cells Stimulated by Histamine*

Qinghua HuDagger , Zu-Xi Yu§, Victor J. Ferrans§dagger, Kazuyo Takeda§, Kaikobad IraniDagger , and Roy C. ZiegelsteinDagger

From the Dagger  Department of Medicine, Division of Cardiology, Johns Hopkins Bayview Medical Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224 and the § Pathology Section, NHLBI, National Institutes of Health, Bethesda, Maryland 20892

Received for publication, February 14, 2002, and in revised form, June 11, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

There is increasing evidence that intracellular reactive oxygen species (ROS) play a role in cell signaling and that the NADPH oxidase is a major source of ROS in endothelial cells. At low concentrations, agonist stimulation of membrane receptors generates intracellular ROS and repetitive oscillations of intracellular Ca2+ concentration ([Ca2+]i) in human endothelial cells. The present study was performed to examine whether ROS are important in the generation or maintenance of [Ca2+]i oscillations in human aortic endothelial cells (HAEC) stimulated by histamine. Histamine (1 µM) increased the fluorescence of 2',7'-dihydrodichlorofluorescin diacetate in HAEC, an indicator of ROS production. This was partially inhibited by the NADPH oxidase inhibitor diphenyleneiodonium (DPI, 10 µM), by the farnesyltransferase inhibitor H-Ampamb-Phe-Met-OH (2 µM), and in HAEC transiently expressing Rac1N17, a dominant negative allele of the protein Rac1, which is essential for NADPH oxidase activity. In indo 1-loaded HAEC, 1 µM histamine triggered [Ca2+]i oscillations that were blocked by DPI or H-Ampamb-Phe-Met-OH. Histamine-stimulated [Ca2+]i oscillations were not observed in HAEC lacking functional Rac1 protein but were observed when transfected cells were simultaneously exposed to a low concentration of hydrogen peroxide (10 µM), which by itself did not alter either [Ca2+]i or levels of inositol 1,4,5-trisphosphate (Ins-1,4,5-P3). Thus, histamine generates ROS in HAEC at least partially via NADPH oxidase activation. NADPH oxidase-derived ROS are critical to the generation of [Ca2+]i oscillations in HAEC during histamine stimulation, perhaps by increasing the sensitivity of the endoplasmic reticulum to Ins-1,4,5-P3.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

There is increasing evidence that intracellular reactive oxygen species (ROS)1 play an important role in cell signaling (1-4). Both vascular smooth muscle cells and endothelial cells are capable of generating ROS (5). A number of enzyme systems likely contribute to ROS generation in endothelial cells, including arachidonic acid-metabolizing systems (6), the mitochondrial electron transport chain (7), xanthine oxidase (8), nitric-oxide synthase (9), the cytochrome P450 enzyme system (10), and endothelial NADPH oxidase (11). The endothelial NADPH oxidase shares some structural features of the multicomponent NADPH oxidase of phagocytes, most of which have been identified in endothelial cells at the RNA or protein level (12-14). Among these include the small GTP-binding protein Rac1, which is necessary for enzyme function. Whereas the oxidase of phagocytes generates large quantities of ROS that are necessary to eliminate engulfed microorganisms, the NADPH oxidase of non-phagocytic cells generates low levels of ROS that appear to have a cell signaling function.

ROS generation by endothelial cells has been observed after stimulation by acetylcholine (15), interleukin-4 (16), interleukin-1 (17), interferon-gamma (17), bradykinin (18, 19), platelet-activating factor (20), vascular endothelial growth factor (21), tumor necrosis factor (22-25), angiotensin II (26, 27), and thrombin (28). In several circumstances, this ROS production has been shown to result from activation of endothelial NADPH oxidase (24, 27, 28). We recently showed that activation of endothelial NADPH oxidase increases the sensitivity of endoplasmic reticulum (ER) Ca2+ stores to inositol 1,4,5-trisphosphate (Ins-1,4,5-P3) (29). Activation of the NADPH oxidase in human aortic endothelial cells (HAEC) shifted the Ins-1,4,5-P3-Ca2+ release dose-response curve to the left and decreased the threshold concentration of Ins-1,4,5-P3 required to release intracellularly stored Ca2+. This effect was blocked by the NADPH oxidase inhibitor diphenyleneiodonium (DPI) and was not observed in cells lacking functional Rac1 protein.

At low concentrations, agonists like histamine (30), bradykinin (31), and thrombin (32) stimulate repetitive oscillations of intracellular Ca2+ concentration ([Ca2+]i) in endothelial cells. The initiation of each Ca2+ spike appears to be due chiefly to the generation of Ins-1,4,5-P3 (33), and the maintenance of oscillations may be related to repetitive cycles of fast activation and slow inactivation of the Ins-1,4,5-P3 receptor by Ca2+ (34, 35). Thus, the observation, that NADPH oxidase-generated ROS increases the sensitivity of intracellular Ca2+ stores to Ins-1,4,5-P3, suggests a potential link between oxidase stimulation and Ca2+ signaling. The following study was therefore performed to determine whether NADPH oxidase-generated ROS affect [Ca2+]i oscillations during histamine stimulation in human endothelial cells.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Endothelial Cell Culture-- Human aortic endothelial cells (HAEC) were obtained as proliferating quaternary cultures (Clonetics, San Diego, CA) and were grown to confluence to passages 5-9 in endothelial cell growth medium supplemented with 2% fetal bovine serum, 10 µg/liter human recombinant epidermal growth factor, 1 mg/liter hydrocortisone, 50 µg/ml gentamicin, 50 ng/ml amphotericin-B, 12 µg/ml bovine brain extract (Clonetics) in a 37 °C humidified atmosphere of 95% air-5% CO2. To measure [Ca2+]i, HAECs were grown on 25-mm-diameter circular glass coverslips (VWR Scientific, Media, PA) precoated with 2% gelatin solution (Sigma Chemical Co.) for at least 2 h at 37 °C. The glass coverslips were washed three times with phosphate-buffered saline (Quality Biological, Inc., Gaithersburg, MD) before cell seeding. After exposure to a solution of 0.025% trypsin and 0.01% EDTA (Sigma), HAECs were plated at an approximate concentration of 1 × 105/ml on the glass coverslips. Cells were used for experiments after reaching ~70% confluence after incubation for 1-2 days at 37 °C in a humidified atmosphere of 95% air-5% CO2.

Measurement of Intracellular ROS Generation in HAEC-- Detection of intracellular ROS was performed by a previously established method using the ROS-sensitive fluorescent probe 2',7'-dihydrodichlorofluorescin diacetate (DCF-DA) and confocal microscopy (1, 36). For measurement of intracellular ROS, HAECs were plated in a chamber slide system (Fisher Sciences, Newark, DE) at a density of 1 × 105 cells/ml and then cultured for 3 days. The cells were washed with HEPES-buffered saline (HBS) and were loaded with 5 µg/ml of DCF-DA (Molecular Probes, Eugene, OR) for 5 min at 37 °C. The fluorescent dichlorofluorescin was quantified by using a laser-scanning confocal microscope (Leica TCS-4D, Heidelberg, Germany) with the excitation and emission wavelengths of 488 and 520 nm, respectively.

Measurement of [Ca2+]i-- HAEC [Ca2+]i was measured as previously described (37) using the fluorescent Ca2+ probe indo 1. Briefly, HAEC in tissue culture dishes were exposed to a solution of 0.025% trypsin and 0.01% EDTA (Sigma Chemical Co., St. Louis, MO) and were then plated at a concentration of ~1 × 105/ml on 25-mm-diameter circular glass coverslips (VWR Scientific, Media, PA) precoated with 2% gelatin solution (Sigma) for at least 2 h at 37 °C. Cells were used for experiments after reaching ~70% confluence after incubation for 1-2 days at 37 °C in a humidified atmosphere of 95% air-5% CO2. To measure [Ca2+]i, HAEC monolayers on glass coverslips were incubated with culture medium containing 10 µM of the ester derivative (acetoxymethyl ester form) of indo 1 (Molecular Probes, Eugene, OR) in a room temperature 95% air-5% CO2 atmosphere for 30 min. The coverslips were then gently washed three times with indicator-free HBS of the following composition (in millimolar): NaCl 137, KCl 4.9, CaCl2 1.5, MgSO4 1.2, NaH2PO4 1.2, D-glucose 15, HEPES 20 (pH adjusted to 7.40 at room temperature with NaOH). The cells were maintained in HBS for at least 30 min before the beginning of the experiment to allow for de-esterification of the indicator. The fluorescence of indo 1 was recorded from single HAEC on coverslips in a perfusion chamber mounted on the stage of a modified Nikon Diaphot inverted epifluorescence microscope. The fluorescence of indo 1 was excited at 350 ± 50 nm using a xenon short arc lamp (UXL-75 XE, Ushio Inc., Japan), and bandpass interference filters (Omega Optical, Brattleboro, VT) with selected wavelength bands of emitted fluorescence at 405 ± 10 nm and 485 ± 10 nm, corresponding to the Ca2+-bound and Ca2+-free forms of the indicator, respectively. Emitted indo 1 fluorescence was collected and measured using a spectrofluorometer (PTI, Deltascan). The photometer had a series of fixed-pinhole diaphragms to regulate the recording field area. Autofluorescence from unloaded HAEC was generally <5% of indo 1-loaded HAEC and was subtracted automatically from indo 1 fluorescence recordings.

To determine [Ca2+]i from indo 1 fluorescence ratios, the intracellular minimum and maximum ratios (Rmin and Rmax, respectively) were determined as previously described (37). To determine Rmin, indo 1-loaded HAECs on the glass coverslips were perfused with a solution containing (in millimolar): NaCl 137, KCl 5.0, MgSO4 1.2, NaH2PO4 1.2, D-glucose 16, HEPES 10, and EGTA 2, pH 7.40. HAECs were then exposed to a solution of similar composition except with 10 mM EGTA and 0.05% Triton X-100. An intracellular Rmax value was determined by first perfusing HAEC with a solution containing 132 mM KCl, 10 mM K-HEPES, 1 mM MgSO4, 2 µM rotenone (Sigma), 2 µM carbonyl cyanide p-trifluoromethoxyphenylhydrozone (Sigma), and 10 ng/ml valinomycin (Calbiochem, La Jolla, CA). HAECs were then exposed to a similar solution containing 2 µM ionomycin (Sigma), 69.2 mM CaCl2, and 100 mM HEPES (free [Ca2+] of 5900 nM). The values of intracellular Rmin and Rmax were used to calculate [Ca2+]i according to the following formula (38): [Ca2+]i = Kd (R - Rmin)/(Rmax - R)(Sf2/Sb2), where Kd is the dissociation constant of indo 1, and Sf2 and Sb2 are the fluorescence intensities at ~490 nm of the Ca2+-free and Ca2+-saturated indicator, respectively. Kd was determined to be 207 nM under the present experimental conditions using an in vitro calibration method.

HAEC Transiently Expressing the Dominant Negative Allele of Rac1-- An adenovirus encoding the Myc epitope-tagged, dominant negative Rac1 cDNA containing a substitution at position 17 (Rac1N17) was used as described previously (4). Expression of the Rac1N17 mutant was confirmed by protein immunoblotting with an antibody to the Myc epitope (9E10, Santa Cruz Biotechnology, Inc., Santa Cruz, CA).

Ins-1,4,5-P3 Measurement-- To measure Ins-1,4,5-P3 levels, HAECs were stimulated with histamine or other agonists, the reaction was stopped by adding M ice-cold trichloroacetic acid, and the cells were maintained for 15 min on ice. The cells were then scraped and centrifuged at 1000 × g for 10 min at 4 °C. The supernatant was removed and incubated for 15 min at room temperature. Levels of 1,4,5-InsP3 in each supernatant were determined using a 3H-label Radioreceptor Assay kit (PerkinElmer Life Sciences, Inc., Boston, MA) according to the manufacturer's instructions. Duplicate measurements were performed for each separate experiment. Cellular Ins-1,4,5-P3 levels were normalized as -fold increase of paired-control experiments in unstimulated HAEC.

Statistical Analysis-- Data are reported as mean ± S.E. Statistical comparisons were made using Student's t test for the paired and the unpaired groups. An analysis of variance was used when multiple comparisons were performed. A difference was considered significant at p < 0.05.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Histamine Stimulates Intracellular ROS Generation in HAEC-- The effect of 1 µM histamine on intracellular ROS generation was examined in DCF-loaded HAEC by confocal microscopy. This concentration of histamine triggers [Ca2+]i oscillations in human endothelial cells (30, 39). As shown in Fig. 1, 1 µM histamine stimulated intracellular ROS generation in a time-dependent manner (Fig. 1A). Histamine increased DCF fluorescence intensity in HAEC by 21.4 ± 8.9%, 54.3 ± 13.8%, and 213.8 ± 33.3% at 1, 5, and 10 min, respectively (p < 0.01 versus control at 5 and 10 min, n = 9 for each). As shown in Fig. 1B, the increase in DCF fluorescence stimulated by histamine was markedly attenuated by the NADPH oxidase inhibitor DPI and by the farnesyltransferase (FTase) inhibitor H-Ampamb-Phe-Met-OH (LC Laboratories, Woburn, MA). FTase inhibitors inhibit the post-translational modification (the covalent addition of a 15-carbon farnesyl group) of Ras family GTP-binding proteins, including Rac1, which is essential for NADPH oxidase activity. Farnesylation is necessary for membrane association and biologic activity of these proteins (40, 41). In the presence of 10 µM DPI or 2 µM FTase inhibitor, concentrations previously shown to inhibit ROS generation in HAEC (42) and fibroblasts (4), respectively, histamine-stimulated DCF fluorescence was inhibited by ~60-70% (60.0 ± 12.0% for DPI and 85.6 ± 18.8% for FTase inhibitor versus 213.8 ± 33.3% at 10 min, p < 0.05 for each). Histamine-stimulated DCF fluorescence was also markedly attenuated in HAEC transiently expressing Rac1N17, a dominant negative allele of Rac1 (4). As shown in Fig. 1C, DCF fluorescence was ~50% lower in cells lacking functional Rac1 protein compared with vector controls (119.1 ± 13.5 versus 228.7 ± 70.5% after 10 min, p < 0.05, n = 4).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of histamine on ROS generation in HAEC. A, representative changes in the fluorescence of 2',7'-dihydrodichlorofluorescin diacetate (DCF-DA) in HAEC treated with 100 µM H2O2 (top), with 1 µM histamine (middle) or unstimulated (bottom) examined by confocal microscopy (×100) and photographed at 0, 5, and 10 min. B, averaged data showing that the increase in DCF fluorescence stimulated by histamine (solid circles) is inhibited by diphenyleneiodonium (DPI, 10 µM, open circles) or a farnesyltransferase (FTase) inhibitor (H-Ampamb-Phe-Met-OH, 2 µM, solid triangles). The change in DCF fluorescence is expressed as a percentage increase above baseline fluorescence after subtraction of the small increase in DCF fluorescence observed in control cells over time (data represent mean ± S.E. of nine experiments for histamine alone and three and five experiments for cells treated with DPI and the FTase inhibitor, respectively; *, p < 0.05; **, p < 0.01 versus control). C, averaged data showing that the increase in DCF fluorescence stimulated by histamine (solid bars) is less in dominant negative Rac transfected cells which lack functional Rac1 protein (open bars). The change in DCF fluorescence is expressed as a percentage increase above baseline fluorescence after subtraction of the small increase in DCF fluorescence observed in control cells over time (data represent mean ± S.E. of four experiments in each group; *, p < 0.05 versus control).

Regulation of Histamine-stimulated [Ca2+]i Oscillations by Intracellular ROS-- As previously demonstrated by our laboratory (39) and others (30), 1 µM histamine triggered [Ca2+]i oscillations in all control HAEC studied (Fig. 2A). By contrast, [Ca2+]i oscillations were not observed in any HAEC expressing the dominant negative form of Rac1 (n = 16). In 14 of 16 cells, no change in [Ca2+]i was noted, and, in the other 2 HAEC expressing the dominant negative form of Rac1, only a single [Ca2+]i spike was observed. Expression of the Rac1N17 mutant did not appear to have a more general effect on Ca2+ signaling, because even in those cells lacking any [Ca2+]i response to 1 µM histamine, the response to 100 µM histamine or to 1 µM ionomycin (Fig. 2B) was preserved. To determine whether expression of the dominant negative isoform of Rac1 inhibited [Ca2+]i oscillations by blocking ROS generation, experiments were performed to determine whether [Ca2+]i oscillations would be triggered by histamine in cells lacking functional Rac1 protein in the presence of exogenous hydrogen peroxide (H2O2). H2O2 was employed for these studies rather than a superoxide-generating system, because our previous work showed that the increased sensitivity of intracellular Ca2+ stores to Ins-1,4,5-P3 stimulated by NADPH oxidase activity was also blocked by catalase but was unaffected by superoxide dismutase (29). As shown in Fig. 2C (top), 10 µM H2O2 alone did not affect [Ca2+]i in HAEC, as previously shown in our laboratory (43). Whereas 1 µM histamine did not stimulate Ca2+ signaling in HAECs expressing the dominant negative form of Rac1, [Ca2+]i oscillations were observed after the simultaneous addition of 10 µM H2O2 in 5 of 7 HAECs examined (Fig. 2C, bottom), and in another a single [Ca2+]i spike was observed. To determine whether the effect of H2O2 was related to an increase in the sensitivity of intracellular Ca2+ stores to Ins-1,4,5-P3 (29) or to an effect on Ins-1,4,5-P3 levels, Ins-1,4,5-P3 levels were measured in HAEC treated with 1 µM histamine or 10 µM H2O2 alone or with the two together. As shown in Fig. 2D, 1 µM histamine alone produced a rapid increase in Ins-1,4,5-P3 levels, with a 1.56 ± 0.25-fold increase evident 1 min after stimulation. H2O2 did not affect Ins-1,4,5-P3 levels by itself and did not alter the effect of histamine on Ins-1,4,5-P3 levels (1.63 ± 0.16-fold increase at 1 min, p = NS compared with histamine alone, n = 3 for each).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   Histamine does not trigger [Ca2+]i oscillations in HAEC lacking functional Rac 1 protein. A, representative tracing of seven similar experiments from indo 1-loaded vector control HAEC exposed to histamine (1 µM) in HEPES buffer with 1.5 mM Ca2+. Histamine stimulated repetitive [Ca2+]i oscillations over at least a 100-min period of observation (slightly less than 30-min shown). B, representative tracing from indo 1-loaded dominant negative Rac-transfected HAEC exposed to 1 µM histamine. Histamine did not trigger any [Ca2+]i spike in 14 of 16 Rac dominant negative transfected HAEC examined; a single [Ca2+]i spike was induced in the remaining two HAEC expressing the dominant negative form of Rac1. Even when histamine failed to affect [Ca2+]i, the response to the Ca2+ ionophore ionomycin (1 µM) was preserved. C, representative tracing from indo 1-loaded HAEC showing that 10 µM H2O2 alone does not affect [Ca2+]i (top). Although 10 µM H2O2 by itself did not trigger [Ca2+]i oscillations in HAEC expressing the dominant negative form of Rac1 (bottom), [Ca2+]i oscillations were observed when 10 µM H2O2 was added during continued exposure to histamine in 5 of 7 HAEC expressing the dominant negative form of Rac1; in another, a single [Ca2+]i spike was observed. D, averaged data showing that 1 µM histamine (solid circles) increases levels of Ins-1,4,5-P3, whereas 10 µM H2O2 has no effect, either alone (solid triangles), or in combination with histamine (open circles). Data represent the mean ± S.E. of three experiments in each group.

Additional experiments were performed to assess whether blocking the generation of ROS by the NADPH oxidase affects histamine-stimulated [Ca2+]i oscillations in HAEC. In these experiments (Fig. 3), [Ca2+]i oscillations were generated and then cells were exposed to histamine-free buffer either alone (Fig. 3A), with DPI (Fig. 3B), or with the FTase inhibitor (Fig. 3C) before a second exposure to histamine. After [Ca2+]i oscillations were generated in the presence of histamine, the washout of histamine resulted in the cessation of oscillations. When the cell was stimulated again with histamine after approximately a 10-min washout period, [Ca2+]i oscillations recurred without any significant difference in oscillation amplitude (Delta indo 1 ratio = 1.20 ± 0.21 versus 1.14 ± 0.24, p = NS) or frequency (0.28 ± 0.02 versus 0.23 ± 0.04 min-1, p = NS) when compared with that observed before the 10-min washout (Fig. 3A). By contrast, repetitive [Ca2+]i oscillations were not observed when either 10 µM DPI (Fig. 3B) or 2 µM FTase inhibitor (Fig. 3C) was present during and after histamine washout. Of note, DPI (up to 20 min) did not affect the content of cellular ATP, which is used for the biosynthesis of Ins-1,4,5-P3, as measured by bioluminescent method (data not shown).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   Histamine-stimulated [Ca2+]i oscillations are blocked by NADPH oxidase inhibition. A, representative tracing of five similar experiments from indo 1-loaded HAEC stimulated sequentially by 1 µM histamine with a 10-min washout period between exposures. Repetitive [Ca2+]i oscillations were observed during histamine stimulation but not during washout. B, representative tracing of four similar experiments from indo 1-loaded HAEC stimulated by 1 µM histamine first in control buffer and then a second time in the presence of 10 µM DPI. Only a single [Ca2+]i spike and no oscillations were observed in the presence of DPI. C, representative tracing of three similar experiments from indo 1-loaded HAEC stimulated by 1 µM histamine first in control buffer and then a second time in the presence of 2 µM FTase inhibitor. Only a single [Ca2+]i spike was observed in two of three HAEC; in a third, several irregularly occurring [Ca2+]i spikes with decreasing amplitude were observed over ~15 min, and then no further increases in [Ca2+]i occurred during the observation period.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

This study shows that histamine, like many other agonists (15-28), stimulates the production of ROS in endothelial cells. Histamine-stimulated ROS production results, at least in part, from activation of the NADPH oxidase and Rac1 signaling, because it is inhibited by the NADPH oxidase inhibitor DPI, by an FTase inhibitor, and in cells lacking functional Rac1 protein.

The generation of ROS by the NADPH oxidase was previously reported when endothelial cells were stimulated by thrombin (28), vascular endothelial growth factor (21), or tumor necrosis factor-alpha (7, 22-25). In the case of tumor necrosis factor, NADPH oxidase-derived ROS were found to be important in activating nuclear factor-kappa B (NF-kappa B) in endothelial cells (24). NF-kappa B activation was previously shown to be redox-sensitive in HeLa cells (36). In HeLa cells, transient expression of a constitutively active Rac1 mutant increased NF-kappa B transcriptional activity, whereas basal and cytokine-stimulated NF-kappa B activity was inhibited in dominant negative Rac1 mutants. This is interesting, because we previously showed that [Ca2+]i oscillations regulate NF-kappa B activity during histamine stimulation in HAEC (39), and now show that NADPH oxidase-derived ROS are critical to the generation of [Ca2+]i oscillations during histamine stimulation.

The effect of NADPH oxidase activation on [Ca2+]i oscillations may derive from the sensitization of the ER Ins-1,4,5-P3 receptor by oxidase-derived ROS. Ins-1,4,5-P3 is critical to the generation of [Ca2+]i oscillations in non-excitable cells (33). Like many other agonists, histamine binds to membrane receptors and activates phospholipase C to hydrolyze phosphatidylinositol 4,5-bisphosphate and to generate diacylglycerol and Ins-1,4,5-P3 (44). The generation of Ins-1,4,5-P3 after agonist stimulation leads to the release of ER Ca2+. [Ca2+]i oscillations are believed to depend on Ins-1,4,5-P3 receptors releasing Ca2+ in "hotspots" in the ER (45) and the subsequent diffusion of this Ca2+ to adjacent sites in the ER, increasing the local sensitivity of the Ins-1,4,5-P3 receptor and inducing further Ca2+ release. Changes in the sensitivity of the ER to Ins-1,4,5-P3 are likely to be important in the generation of repetitive [Ca2+]i spikes. Redox sensitivity of the Ins-1,4,5-P3 receptor has previously been reported in hepatocytes (46-48), and we previously showed that NADPH oxidase activation increases the sensitivity of intracellular Ca2+ stores to Ins-1,4,5-P3 in HAEC. The finding, that 10 µM H2O2 "restores" [Ca2+]i oscillations in histamine-stimulated HAEC expressing the dominant negative form of Rac1 but does not affect Ins-1,4,5-P3 levels in histamine-stimulated HAEC, is consistent with the notion that histamine-stimulated ROS increase Ins-1,4,5-P3 receptor sensitivity and thereby affect the generation of [Ca2+]i oscillations.

Histamine-stimulated ROS may also affect upstream signaling pathways in HAEC. For example, we recently showed that activation of phospholipase D (PLD), which exhibits redox sensitivity in endothelial cells (49), regulates [Ca2+]i oscillation frequency in HAEC during histamine stimulation (50). It is not likely that the effect of histamine-stimulated ROS on the generation of [Ca2+]i oscillations is related to PLD signaling, however, because time-dependent activation of PLD by histamine in HAEC is not rapid enough to affect generation of oscillations. Stimulation of HAEC by histamine activates PLD by 5 min, but no significant effect is observed 1 min after stimulation. Moreover, inhibition of PLD decreases oscillation frequency, but does not inhibit the generation of [Ca2+]i oscillations during histamine stimulation (50). Alternatively, histamine-stimulated ROS may modulate [Ca2+]i oscillations by an effect on PLC-gamma , because generation of Ins-1,4,5-P3 by agonists like bradykinin appears to be secondary to tyrosine phosphorylation of PLC-gamma 1 (51) and H2O2 is known to activate PLC-gamma (52). We do not believe this mechanism is likely to play a role during histamine stimulation, because 1 µM histamine stimulated only weak tyrosine phosphorylation of PLC-gamma 1 and histamine-stimulated tyrosine phosphorylation of PLC-gamma 2 was not inhibited by DPI, by an FTase inhibitor, or in cells lacking functional Rac1 protein (data not shown).

ROS may also be important in the generation of [Ca2+]i oscillations, because of an effect on other redox-sensitive Ca2+ release mechanisms that are activated by histamine. For example, the ryanodine receptor (RyR) may be important in histamine-stimulated Ca2+ signaling. It was previously shown that blocking ryanodine-sensitive Ca2+ release inhibits [Ca2+]i oscillations in endothelial cells stimulated by histamine (53). Redox regulation of the RyR is well-established in cardiac and skeletal muscle, with sulfhydryl oxidation, S-nitrosylation, or modification of sulfhydryl groups of the RyR by other oxidants increasing Ca2+ release channel activity (54). Hyper-reactive cysteine moieties may represent biochemical components of a transmembrane redox sensor within the RyR channel complex that conveys information about localized changes in redox potential produced by different stimuli (55, 56).

The finding that ROS play a role in agonist-stimulated Ca2+ signaling is novel and important in cell biology, reinforcing the relatively new concept that ROS are not only important pathophysiologically but also play major roles in cell signaling. It was recently shown, for example, that epidermal growth factor increases [Ca2+]i in fibroblasts without affecting inositol phosphates but rather via the production of H2O2 regulated by Rac and RhoA (57). This finding is interesting in light of our previous work showing that H2O2 increases the sensitivity of the ER Ca2+ store to Ins-1,4,5-P3 (29) and that H2O2 generates [Ca2+]i oscillations in endothelial cells (43), even though H2O2 itself does not stimulate Ins-1,4,5-P3 production, as shown in this work and by others (58).

The present study shows that elevated levels of Ins-1,4,5-P3 alone may not be sufficient to initiate repetitive [Ca2+]i spiking behavior in HAEC during histamine stimulation. Although histamine increases levels of Ins-1,4,5-P3 (44), the generation of ROS during histamine stimulation is necessary for oscillations to be triggered. More specifically, it appears that NADPH oxidase-derived ROS are important in histamine-triggered Ca2+ signaling, because oscillations were not observed in the presence of DPI, an FTase inhibitor or in dominant negative Rac1 transfected cells. The critical role of ROS in the generation of [Ca2+]i oscillations is further supported by the finding that 10 µM H2O2 "restored" [Ca2+]i oscillations in histamine-stimulated HAEC expressing the dominant negative form of Rac1, even though this concentration of H2O2 alone did not affect Ca2+ signaling or Ins-1,4,5-P3 levels. Taken together, these data suggest that histamine activates an NADPH oxidase in HAEC, resulting in the production of ROS that increase the sensitivity of the Ins-1,4,5-P3 receptor to Ins-1,4,5-P3 and thereby play a role in the generation of [Ca2+]i oscillations.

    ACKNOWLEDGEMENTS

We thank Dr. Steve N. Georas and Dr. Jia Guo for expert technical assistance and insightful comments.

    FOOTNOTES

* This work was supported by a Beginning-Grant-in-Aid 0060165U from the American Heart Association Mid-Atlantic Affiliate (to Q. H.) and by National Institutes of Health Grant R01 HL63720 (to R. C. Z.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

dagger Dr. Ferrans passed away shortly before submission of the manuscript.

To whom correspondence should be addressed: Dept. of Medicine, Division of Cardiology, Johns Hopkins Bayview Medical Center, 5501 Hopkins Bayview Circle 1A32, Baltimore, MD 21224-2780. Tel.: 410-550-6728; Fax: 410-550-1094; E-mail: ginghuaa@jhmi.edu.

Published, JBC Papers in Press, July 1, 2002, DOI 10.1074/jbc.M201550200

    ABBREVIATIONS

The abbreviations used are: ROS, reactive oxygen species; Ins-1, 4,5-P3, inositol 1,4,5-triphosphate; HAEC, human aortic endothelial cells; [Ca2+]i, intracellular free calcium; ER, endoplasmic reticulum; DPI, diphenyleneiodonium; DCF-DA, 2',7'-dihydrodichlorofluorescin diacetate; HBS, HEPES-buffered saline; PLD, phospholipase D; PLC, phospholipase C; RyR, ryanodine receptor.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Sundaresan, M., Yu, Z.-X., Ferrans, V. J., Irani, K., and Finkel, T. (1995) Science 270, 296-299[Abstract/Free Full Text]
2. Lander, H. M., Milbank, A. J., Tauras, J. M., Hajjar, D. P., Hempstead, B. L., Schwartz, G. D., Kraemer, R. T., Mirza, U. A., Chait, B. T., Campbell-Burk, S., and Quilliam, L. A. (1996) Nature 381, 380-381[CrossRef][Medline] [Order article via Infotrieve]
3. Lander, H. M. (1997) FASEB J. 11, 118-124[Abstract]
4. Irani, K., Xia, Y., Zweier, J. L., Sollott, S. J., Der, C. J., Fearon, E. R., Sundaresan, M., Finkel, T., and Goldschmidt-Clermont, P. J. (1997) Science 275, 1649-1652[Abstract/Free Full Text]
5. Irani, K. (2000) Circ. Res. 87, 179-183[Abstract/Free Full Text]
6. Cosentino, F., Sill, J. C., and Katusic, Z. S. (1994) Hypertension 23, 229-235[Abstract/Free Full Text]
7. Corda, S., Laplace, C., Vicaut, E., and Duranteau, J. (2001) Am. J. Respir. Cell Mol. Biol. 24, 762-768[Abstract/Free Full Text]
8. Zweier, J. L., Kuppusamy, P., and Lutty, G. A. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 4046-4050[Abstract/Free Full Text]
9. Kerr, S., Brosnan, M. J., McIntyre, M., Reid, J. L., Dominiczak, A. F., and Hamilton, C. A. (1999) Hypertension 33, 1353-1358[Abstract/Free Full Text]
10. Fleming, I., Michaelis, U. R., Bredenkotter, D., Fisslthaler, B., Dehghani, F., Brandes, R. P., and Busse, R. (2001) Circ. Res. 88, 44-51[Abstract/Free Full Text]
11. Babior, B. M. (2000) IUBMB Life 50, 267-269[CrossRef][Medline] [Order article via Infotrieve]
12. Jones, S. A., O'Donnell, V. B., Wood, J. D., Broughton, J. P., Hughes, E. J., and Jones, O. T. (1996) Am. J. Physiol. 271, H1626-H1634[Medline] [Order article via Infotrieve]
13. Bayraktutan, U., Blayney, L., and Shah, A. M. (2000) Arterioscler. Thromb. Vasc. Biol. 20, 1903-1911[Abstract/Free Full Text]
14. Li, J. M., and Shah, A. M. (2001) Cardiovasc. Res. 52, 477-486[Abstract/Free Full Text]
15. Matoba, T., Shimokawa, H., Nakashima, M., Hirakawa, Y., Mukai, Y., Hirano, K., Kanaide, H., and Takeshita, A. (2000) J. Clin. Invest. 106, 1521-1530[Medline] [Order article via Infotrieve]
16. Lee, Y. W., Kuhn, H., Hennig, B., Neish, A. S., and Toborek, M. (2001) J. Mol. Cell. Cardiol. 33, 83-94[CrossRef][Medline] [Order article via Infotrieve]
17. Matsubara, T., and Ziff, M. (1986) J. Immunol. 137, 3295-3298[Abstract]
18. Holland, J. A., Pritchard, K. A., Pappolla, M. A., Wolin, M. S., Rogers, N. J., and Stemerman, M. B. (1990) J. Cell. Physiol. 143, 21-25[CrossRef][Medline] [Order article via Infotrieve]
19. Schimizu, S.-I., Ishii, M., Yamamoto, T., Kawanishi, T., Momose, K., and Kuroiwa, Y. (1994) Res. Commun. Chem. Pathol. Pharmacol. 84, 301-314[Medline] [Order article via Infotrieve]
20. Gardner, C. R., Laskin, J. D., and Laskin, D. L. (1993) J. Leukocyte Biol. 53, 190-196[Abstract]
21. Abid, M. R., Tsai, J. C., Spokes, K. C., Deshpande, S. S., Irani, K., and Aird, W. C. (2001) FASEB J. 15, 2548-2550[Free Full Text]
22. Toborek, M., Blanc, E. M., Kaiser, S., Mattson, M. P., and Hennig, B. (1997) J. Lipid Res. 38, 2155-2167[Abstract]
23. Murphy, H. S., Shayman, J. A., Till, G. O., Mahrougui, M., Owens, C. B., Ryan, U. S., and Ward, P. A. (1992) Am. J. Physiol. 263, L51-L59[Medline] [Order article via Infotrieve]
24. Deshpande, S. S., Angkeow, P., Huang, J., Ozaki, M., and Irani, K. (2000) FASEB J. 14, 1705-1714[Abstract/Free Full Text]
25. Rahman, A., Anwar, K. N., and Malik, A. B. (2000) Am. J. Physiol. 279, C906-C914
26. Zhang, H., Schmeisser, A., Garlichs, C. D., Plotze, K., Damme, U., Mugge, A., and Daniel, W. G. (1999) Cardiovasc. Res. 44, 215-222[Abstract/Free Full Text]
27. Lang, D., Mosfer, S. I., Shakesby, A., Donaldson, F., and Lewis, M. J. (2000) Circ. Res. 86, 463-469[Abstract/Free Full Text]
28. Holland, J. A., Meyer, J. W., Chang, M. M., O'Donnell, R. W., Johnson, D. K., and Ziegler, L. M. (1998) Endothelium. 6, 113-121[Medline] [Order article via Infotrieve]
29. Hu, Q., Zheng, G., Zweier, J. L., Deshpande, S., Irani, K., and Ziegelstein, R. C. (2000) J. Biol. Chem. 275, 15749-15757[Abstract/Free Full Text]
30. Jacob, R., Merritt, J. E., Hallam, T. J., and Rink, T. J. (1988) Nature 335, 40-45[CrossRef][Medline] [Order article via Infotrieve]
31. Carter, T. D., Bogle, R. G., and Bjaaland, T. (1991) Biochem. J. 278, 697-704[Medline] [Order article via Infotrieve]
32. Rink, T. J., and Hallam, T. J. (1989) Cell Calcium 10, 385-395[CrossRef][Medline] [Order article via Infotrieve]
33. Clapham, D. E. (1995) Cell 80, 259-268[CrossRef][Medline] [Order article via Infotrieve]
34. Sneyd, J., Keizer, J., and Sanderson, M. J. (1995) FASEB J. 9, 1463-1472[Abstract]
35. Hajnoczky, G., and Thomas, A. P. (1997) EMBO J. 16, 3533-3543[CrossRef][Medline] [Order article via Infotrieve]
36. Sulciner, D. J., Irani, K., Yu, Z. X., Ferrans, V. J., Goldschmidt-Clermont, P., and Finkel, T. (1996) Mol. Cell. Biol. 16, 7115-7121[Abstract]
37. Ziegelstein, R. C., Cheng, L., Blank, P. S., Spurgeon, H. A., Lakatta, E. G., Hansford, R. G., and Capogrossi, M. C. (1993) Am. J. Physiol. 265, H1424-H1433[Medline] [Order article via Infotrieve]
38. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985) J. Biol. Chem. 260, 3440-3450[Abstract/Free Full Text]
39. Hu, Q., Deshpande, S., Irani, K., and Ziegelstein, R. C. (1999) J. Biol. Chem. 274, 33995-33998[Abstract/Free Full Text]
40. Didsbury, J. R., Uhing, R. J., and Snyderman, R. (1990) Biochem. Biophys. Res. Commun. 171, 804-812[CrossRef][Medline] [Order article via Infotrieve]
41. Kinsella, B. T., Erdman, R. A., and Maltese, W. A. (1991) J. Biol. Chem. 266, 9786-9794[Abstract/Free Full Text]
42. Kovacic, H. N., Irani, K., and Goldschmidt-Clermont, P. J. (2001) J. Biol. Chem. 276, 45856-45861[Abstract/Free Full Text]
43. Hu, Q., Corda, S., Zweier, J. L., Capogrossi, M. C., and Ziegelstein, R. C. (1998) Circulation 97, 268-275[Abstract/Free Full Text]
44. Pollock, W. K., Wreggett, K. A., and Irvine, R. F. (1988) Biochem. J. 256, 371-376[Medline] [Order article via Infotrieve]
45. Lechleiter, J., Girard, S., Peralta, E., and Clapham, D. (1991) Science 252, 123-126[Abstract/Free Full Text]
46. Renard-Rooney, D. C., Joseph, S. K., Seitz, M. B., and Thomas, A. P. (1995) Biochem. J. 310, 185-192[Medline] [Order article via Infotrieve]
47. Renard, D. C., Seitz, M. B., and Thomas, A. P. (1992) Biochem. J. 284, 507-512[Medline] [Order article via Infotrieve]
48. Nomura, T., Higashi, K., Hoshino, M., Saso, K., Itou, M., and Hoek, J. B. (1996) Alcohol. Clin. Exp. Res. 20, 325A-329A[Medline] [Order article via Infotrieve]
49. Parinandi, N. L., Scribner, W. M., Vepa, S., Shi, S., and Natarajan, V. (1999) Antioxid. Redox Signal. 1, 193-210[Medline] [Order article via Infotrieve]
50. Hu, Q., Natarajan, V., and Ziegelstein, R. C. (2002) Biochem. Biophys. Res. Commun. 292, 325-332[CrossRef][Medline] [Order article via Infotrieve]
51. Venema, V. J., Ju, H., Sun, J., Eaton, D. C., Marrero, M. B., and Venema, R. C. (1998) Biochem. Biophys. Res. Commun. 246, 70-75[CrossRef][Medline] [Order article via Infotrieve]
52. Goldkorn, T., Balaban, N., Matsukuma, K., Chea, V., Gould, R., Last, J., Chan, C., and Chavez, C. (1998) Am. J. Respir. Cell Mol. Biol. 19, 786-798[Abstract/Free Full Text]
53. Paltauf-Doburzynska, J., Frieden, M., Spitaler, M., and Graier, W. F. (2000) J. Physiol. 524, 701-713[Abstract/Free Full Text]
54. Anzai, K., Ogawa, K., Ozawa, T., and Yamamoto, H. (2000) Antioxid. Redox Signal. 2, 35-40[Medline] [Order article via Infotrieve]
55. Pessah, I. N., and Feng, W. (2000) Antioxid. Redox Signal. 2, 17-25[Medline] [Order article via Infotrieve]
56. Feng, W., Liu, G., Allen, P. D., and Pessah, I. N. (2000) J. Biol. Chem. 275, 35902-35907[Abstract/Free Full Text]
57. Lee, Z. W., Kweon, S. M., Kim, S. J., Kim, J. H., Cheong, C., Park, Y. M., and Ha, K. S. (2000) Cell Signal. 12, 91-98[CrossRef][Medline] [Order article via Infotrieve]
58. Vercellotti, G. M., Severson, S. P., Duane, P., and Moldow, C. F. (1991) J. Lab. Clin. Med. 117, 15-24[Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. H. Edwards, Y. Li, and T. M. Griffith
Hydrogen Peroxide Potentiates the EDHF Phenomenon by Promoting Endothelial Ca2+ Mobilization
Arterioscler. Thromb. Vasc. Biol., October 1, 2008; 28(10): 1774 - 1781.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. Zhu, Y. Luo, T. Chen, F. Chen, T. Wang, and Q. Hu
Ca2+ oscillation frequency regulates agonist-stimulated gene expression in vascular endothelial cells
J. Cell Sci., August 1, 2008; 121(15): 2511 - 2518.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. M. Davidson and M. R. Duchen
Endothelial Mitochondria: Contributing to Vascular Function and Disease
Circ. Res., April 27, 2007; 100(8): 1128 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev, January 1, 2007; 87(1): 245 - 313.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
L. Cardenas, S. T. McKenna, J. G. Kunkel, and P. K. Hepler
NAD(P)H Oscillates in Pollen Tubes and Is Correlated with Tip Growth
Plant Physiology, December 1, 2006; 142(4): 1460 - 1468.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. Camello-Almaraz, P. J. Gomez-Pinilla, M. J. Pozo, and P. J. Camello
Mitochondrial reactive oxygen species and Ca2+ signaling
Am J Physiol Cell Physiol, November 1, 2006; 291(5): C1082 - C1088.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Hong, S. J. Moon, H. M. Byun, M. S. Kim, H. Jo, Y. S. Bae, S.-I. Lee, M. D. Bootman, H. L. Roderick, D. M. Shin, et al.
Critical Role of Phospholipase C{gamma}1 in the Generation of H2O2-evoked [Ca2+]i Oscillations in Cultured Rat Cortical Astrocytes
J. Biol. Chem., May 12, 2006; 281(19): 13057 - 13067.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. Brueckl, S. Kaestle, A. Kerem, H. Habazettl, F. Krombach, H. Kuppe, and W. M. Kuebler
Hyperoxia-Induced Reactive Oxygen Species Formation in Pulmonary Capillary Endothelial Cells In Situ
Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 453 - 463.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. K. Aley, K. E. Porter, J. P. Boyle, P. J. Kemp, and C. Peers
Hypoxic Modulation of Ca2+ Signaling in Human Venous Endothelial Cells: MULTIPLE ROLES FOR REACTIVE OXYGEN SPECIES
J. Biol. Chem., April 8, 2005; 280(14): 13349 - 13354.
[Abstract] [Full Text] [PDF]

<

Home page